# Clal Insurance Enterprises Holdings

> Clal Insurance Enterprises Holdings is a VC fund backing Health Care. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Kiryat Gat, Israel
- Total investments: 5
- Last investment: Nov 2022
- Lead investor: 20%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/clal-insurance
- Website: http://www.clal.co.il/

Clal Insurance Enterprises Holdings is a VC fund in Kiryat Gat focused on Health Care and EdTech. Clal Insurance Enterprises Holdings provides insurance and financial services in Israel. The company’s Long-term Savings segment offers insurance covering various risks, such as life, death, disability, loss of work capacity, and health, as well as provides pension and provident funds. Its Health Insurance segment provides long term care,medical expense, surgeries, transplants, personal accidents, travel, dental, foreign workers, and other insurance services. The company’s Non-Life Insurance segment offers liability and property, credit, personal accident, and other insurance services. Its Other segment engages in the credit and financing activities; and insurance agency operations. The company primarily offers its products and services for individuals, policyholders, self-employed workers, and collectives. Clal Insurance Enterprises Holdings Ltd. was founded in 1987 and is based in Tel Aviv, Israel.

## Contacts

5 contacts available for Clal Insurance Enterprises Holdings. Shizune tracks 2 team members at Clal Insurance Enterprises Holdings. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/clal-insurance-enterprises-holdings?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| EdTech | 1 | 20% |
| Fitness | 1 | 20% |
| Medical | 1 | 20% |
| Database | 1 | 20% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series E | 2 | 40% |
| Series A | 1 | 20% |
| Series B | 1 | 20% |
| Funding Round | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 2 | 40% |
| United States | 2 | 40% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Izzy Cohen | CEO | 0 | — |
| Yulia Tsvibel | QA tester | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Simplilearn | Simplilearn helps professionals across the globe realize their dream careers. As a destination for certification training courses, the company caters to professionals across industries and functions. Through a combination of proven training content, blended delivery model and next-gen customer experience, Simplilearn offers courses that helpprofessionals get the edge they want in their careers. With study centers across the globe, Simplilearn offers 200+ certification courses in Project Management, IT Service Management, Microsoft Certification, Quality Management, Financial Management and more. Rated by Deloitte as the 4th fastest growing technology firm in India and 11th in Asia, and by the IAMAI as the best educational website, the company has trained over 400,000+ professionals across 150+ countries. Simplilearn is the Global Registered Education Provider (REP) of PMI, USA, Accredited Training Organization (ATO) by APMG International, UK, Registered Education Provider (REP) of Scrum Alliance Inc., and Accredited Examination Center (AEC) by EXIN, TUV-SUD, EC Council and PEOPLECERT. In September 2013, Simplilearn raised $10-million in Series B funding from Helion Venture Partners and Kalaari Capital to diversify and expand its course catalog. Simplilearn’s mission is to consistently provide best-in-class training to working professionals through proven content, robust technology and a focus to achieve 100% customer delight. For more information, visit www.simplilearn.com | $45M | Series E | Nov 16, 2022 |  |
| MeMed | MeMed Diagnostics is a personalized diagnostics company founded in 2009. They are here to improve patient care, empower physicians, and lower health-care costs through rapid and actionable diagnostics for infectious diseases. Their main focus is preventing antibiotics misuse.Antibiotics are the most prescribed class of drugs worldwide with aglobal market of 25-30 billion $US. Up to 70% of antibiotics are estimated to be prescribed inappropriately, making them the most misused drug class in the world. Antibiotics misuse leads to ineffective treatment, emergence of resistant strains of bacteria, and is estimated to cost healthcare systems worldwide tens of billions of dollars annually. Their platform, the ImmunoDx™, leverages the world’s most accurate diagnostic system for differentiating bacteria from viruses, crafted by nature, the body’s immune system.ImmunoDx™ combines proprietary biomarkers, algorithms, and clinical know-how to identify the source of infection (virus vs bacteria, bacterial spectrum), by decoding the immune system`s differential response to different pathogens. This unique approach enables ImmunoDx™ to address some of the major challenges facing currently available diagnostics for infectious diseases. | $93M | Series E | Jan 10, 2022 |  |
| Silk | Silk is the leading platform to quickly move mission-critical data to the cloud and to keep it operating at performance standards on par with even the fastest on-prem environments. Silk works with global enterprise companies and cloud providers to ensure a seamless, efficient, and smooth migration process, followed by unparalleled performancespeeds for all data and applications in the cloud.The platform makes cloud environments run 10x faster and the entire application stack is more resilient to any infrastructure hiccups or malfunctions. Silk has offices in Israel and is headquartered in Needham, MA. For more information, visit https://silk.us/ | $55M | Series B | Jul 07, 2021 |  |
| Silk | Silk is the leading platform to quickly move mission-critical data to the cloud and to keep it operating at performance standards on par with even the fastest on-prem environments. Silk works with global enterprise companies and cloud providers to ensure a seamless, efficient, and smooth migration process, followed by unparalleled performancespeeds for all data and applications in the cloud.The platform makes cloud environments run 10x faster and the entire application stack is more resilient to any infrastructure hiccups or malfunctions. Silk has offices in Israel and is headquartered in Needham, MA. For more information, visit https://silk.us/ | $55M | Series A | Jul 07, 2021 |  |
| OrCam Technologies | OrCam harnesses the power of artificial vision in an intuitive portable device that compensates for lost visual abilities. OrCam has created a technologically advanced device unique in its ability to provide visual aid through a discreet wearable platform and simple easy-to-use interface which serves to enhance the daily lives of people withvision loss. The OrCam device is a smart camera mounted on the frames of your eyeglasses, which “sees” text, recognizes objects and “whispers” in your ear. | $30.4M |  | Feb 20, 2018 |  |

5 of 5 investments shown.

## Co-investors
- [Clal Insurance](https://shizune.co/investors/profile/clal-insurance) — VC Fund, 3 deals together
- [Meitav Investment House](https://shizune.co/investors/profile/meitav-investment-house) — VC Fund, 3 deals together
- [Poalim Equity](https://shizune.co/investors/profile/poalim-equity) — VC Fund, 3 deals together
- [Globespan Capital Partners](https://shizune.co/investors/profile/globespan-capital-partners) — VC Fund, 2 deals together
- [Ibex Investors](https://shizune.co/investors/profile/ibex-investors) — VC Fund, 2 deals together
- [Menora Mivtachim](https://shizune.co/investors/profile/mivtahim-israels-largest-pension-fund) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Krungsri Finnovate](https://shizune.co/investors/profile/krungsri-finnovate) — VC Fund
- [Munich Venture Partners](https://shizune.co/investors/profile/munich-venture-partners) — VC Fund
- [yet2Ventures](https://shizune.co/investors/profile/yet2ventures) — VC Fund

## FAQ

### What does Clal Insurance Enterprises Holdings invest in?

Clal Insurance Enterprises Holdings invests primarily in Health Care, EdTech and Fitness startups, most often at Series E and Series A stage. Most of the 5 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Clal Insurance Enterprises Holdings?

Public channels for Clal Insurance Enterprises Holdings include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Clal Insurance Enterprises Holdings?

The team at Clal Insurance Enterprises Holdings includes Izzy Cohen (CEO) and Yulia Tsvibel (QA tester). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co